Inhibition of p-chlorophenoxyisobutyrate by 1-methyl-2-mercaptoimidazole and related compounds.
D000818:Animals; D001151:Arsenic / Q000494:pharmacology; D002994:Clofibrate / Q000037:antagonists & inhibitors*; D004790:Enzyme Induction / Q000187:drug effects; D005753:Gastric Mucosa / Q000378:metabolism; D005993:Glycerolphosphate Dehydrogenase / Q000378:metabolism; D007093:Imidazoles / Q000494:pharmacology; D007421:Intestine, Small / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008291:Malate Dehydrogenase / Q000378:metabolism; D008297:Male; D008713:Methimazole / Q000494:pharmacology*; D008930:Mitochondria, Liver / Q000201:enzymology; D009929:Organ Size; D010084:Oxidation-Reduction; D010169:Palmitic Acids / Q000378:metabolism; D051381:Rats; D013438:Sulfhydryl Compounds / Q000494:pharmacology; D013963:Thyroid Hormones / Q000494:pharmacology; D013997:Time Factors; D014280:Triglycerides / Q000097:blood; D014316:Tritium
D007093:Imidazoles; D010169:Palmitic Acids; D013438:Sulfhydryl Compounds; D013963:Thyroid Hormones; D014280:Triglycerides; D014316:Tritium; D008713:Methimazole; D005993:Glycerolphosphate Dehydrogenase; D008291:Malate Dehydrogenase; D002994:Clofibrate; D001151:Arsenic